List of Tables
Table 1. Global Cardiac Disease Stem Cell Therapy Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Autologous
Table 3. Key Players of Allogeneic
Table 4. Global Cardiac Disease Stem Cell Therapy Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 5. Global Cardiac Disease Stem Cell Therapy Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Cardiac Disease Stem Cell Therapy Market Size by Region (US$ Million), 2021–2026
Table 7. Global Cardiac Disease Stem Cell Therapy Market Share by Region (2021–2026)
Table 8. Global Cardiac Disease Stem Cell Therapy Forecasted Market Size by Region (US$ Million), 2027–2032
Table 9. Global Cardiac Disease Stem Cell Therapy Market Share by Region (2027–2032)
Table 10. Cardiac Disease Stem Cell Therapy Market Trends
Table 11. Cardiac Disease Stem Cell Therapy Market Drivers
Table 12. Cardiac Disease Stem Cell Therapy Market Challenges
Table 13. Cardiac Disease Stem Cell Therapy Market Restraints
Table 14. Global Cardiac Disease Stem Cell Therapy Revenue by Players (US$ Million), 2021–2026
Table 15. Global Cardiac Disease Stem Cell Therapy Market Share by Players (2021–2026)
Table 16. Global Top Cardiac Disease Stem Cell Therapy Players by Tier (Tier 1, Tier 2, and Tier 3), based on Cardiac Disease Stem Cell Therapy Revenue, 2025
Table 17. Ranking of Global Top Cardiac Disease Stem Cell Therapy Companies by Revenue (US$ Million) in 2025
Table 18. Global 5 Largest Players Market Share by Cardiac Disease Stem Cell Therapy Revenue (CR5 and HHI), 2021–2026
Table 19. Global Key Players of Cardiac Disease Stem Cell Therapy, Headquarters and Area Served
Table 20. Global Key Players of Cardiac Disease Stem Cell Therapy, Products and Applications
Table 21. Global Key Players of Cardiac Disease Stem Cell Therapy, Date of General Availability (GA)
Table 22. Mergers and Acquisitions, Expansion Plans
Table 23. Global Cardiac Disease Stem Cell Therapy Market Size by Type (US$ Million), 2021–2026
Table 24. Global Cardiac Disease Stem Cell Therapy Revenue Market Share by Type (2021–2026)
Table 25. Global Cardiac Disease Stem Cell Therapy Forecasted Market Size by Type (US$ Million), 2027–2032
Table 26. Global Cardiac Disease Stem Cell Therapy Revenue Market Share by Type (2027–2032)
Table 27. Global Cardiac Disease Stem Cell Therapy Market Size by Application (US$ Million), 2021–2026
Table 28. Global Cardiac Disease Stem Cell Therapy Revenue Market Share by Application (2021–2026)
Table 29. Global Cardiac Disease Stem Cell Therapy Forecasted Market Size by Application (US$ Million), 2027–2032
Table 30. Global Cardiac Disease Stem Cell Therapy Revenue Market Share by Application (2027–2032)
Table 31. North America Cardiac Disease Stem Cell Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 32. North America Cardiac Disease Stem Cell Therapy Market Size by Country (US$ Million), 2021–2026
Table 33. North America Cardiac Disease Stem Cell Therapy Market Size by Country (US$ Million), 2027–2032
Table 34. Europe Cardiac Disease Stem Cell Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 35. Europe Cardiac Disease Stem Cell Therapy Market Size by Country (US$ Million), 2021–2026
Table 36. Europe Cardiac Disease Stem Cell Therapy Market Size by Country (US$ Million), 2027–2032
Table 37. Asia-Pacific Cardiac Disease Stem Cell Therapy Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 38. Asia-Pacific Cardiac Disease Stem Cell Therapy Market Size by Region (US$ Million), 2021–2026
Table 39. Asia-Pacific Cardiac Disease Stem Cell Therapy Market Size by Region (US$ Million), 2027–2032
Table 40. Latin America Cardiac Disease Stem Cell Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 41. Latin America Cardiac Disease Stem Cell Therapy Market Size by Country (US$ Million), 2021–2026
Table 42. Latin America Cardiac Disease Stem Cell Therapy Market Size by Country (US$ Million), 2027–2032
Table 43. Middle East & Africa Cardiac Disease Stem Cell Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 44. Middle East & Africa Cardiac Disease Stem Cell Therapy Market Size by Country (US$ Million), 2021–2026
Table 45. Middle East & Africa Cardiac Disease Stem Cell Therapy Market Size by Country (US$ Million), 2027–2032
Table 46. Pharmicell Company Details
Table 47. Pharmicell Business Overview
Table 48. Pharmicell Cardiac Disease Stem Cell Therapy Product
Table 49. Pharmicell Revenue in Cardiac Disease Stem Cell Therapy Business (US$ Million), 2021–2026
Table 50. Pharmicell Recent Development
Table 51. Gencell Company Details
Table 52. Gencell Business Overview
Table 53. Gencell Cardiac Disease Stem Cell Therapy Product
Table 54. Gencell Revenue in Cardiac Disease Stem Cell Therapy Business (US$ Million), 2021–2026
Table 55. Gencell Recent Development
Table 56. BlueRock Therapeutics Company Details
Table 57. BlueRock Therapeutics Business Overview
Table 58. BlueRock Therapeutics Cardiac Disease Stem Cell Therapy Product
Table 59. BlueRock Therapeutics Revenue in Cardiac Disease Stem Cell Therapy Business (US$ Million), 2021–2026
Table 60. BlueRock Therapeutics Recent Development
Table 61. Cellino Biotech Company Details
Table 62. Cellino Biotech Business Overview
Table 63. Cellino Biotech Cardiac Disease Stem Cell Therapy Product
Table 64. Cellino Biotech Revenue in Cardiac Disease Stem Cell Therapy Business (US$ Million), 2021–2026
Table 65. Cellino Biotech Recent Development
Table 66. Mesoblast Company Details
Table 67. Mesoblast Business Overview
Table 68. Mesoblast Cardiac Disease Stem Cell Therapy Product
Table 69. Mesoblast Revenue in Cardiac Disease Stem Cell Therapy Business (US$ Million), 2021–2026
Table 70. Mesoblast Recent Development
Table 71. BioCardia Company Details
Table 72. BioCardia Business Overview
Table 73. BioCardia Cardiac Disease Stem Cell Therapy Product
Table 74. BioCardia Revenue in Cardiac Disease Stem Cell Therapy Business (US$ Million), 2021–2026
Table 75. BioCardia Recent Development
Table 76. Cedars-Sinai Company Details
Table 77. Cedars-Sinai Business Overview
Table 78. Cedars-Sinai Cardiac Disease Stem Cell Therapy Product
Table 79. Cedars-Sinai Revenue in Cardiac Disease Stem Cell Therapy Business (US$ Million), 2021–2026
Table 80. Cedars-Sinai Recent Development
Table 81. Stem Cells Transplant Institute Company Details
Table 82. Stem Cells Transplant Institute Business Overview
Table 83. Stem Cells Transplant Institute Cardiac Disease Stem Cell Therapy Product
Table 84. Stem Cells Transplant Institute Revenue in Cardiac Disease Stem Cell Therapy Business (US$ Million), 2021–2026
Table 85. Stem Cells Transplant Institute Recent Development
Table 86. CCTRN Company Details
Table 87. CCTRN Business Overview
Table 88. CCTRN Cardiac Disease Stem Cell Therapy Product
Table 89. CCTRN Revenue in Cardiac Disease Stem Cell Therapy Business (US$ Million), 2021–2026
Table 90. CCTRN Recent Development
Table 91. Help Therapeutics Co., Ltd. Company Details
Table 92. Help Therapeutics Co., Ltd. Business Overview
Table 93. Help Therapeutics Co., Ltd. Cardiac Disease Stem Cell Therapy Product
Table 94. Help Therapeutics Co., Ltd. Revenue in Cardiac Disease Stem Cell Therapy Business (US$ Million), 2021–2026
Table 95. Help Therapeutics Co., Ltd. Recent Development
Table 96. Beijing Cellapy biotechnology Co., LTD Company Details
Table 97. Beijing Cellapy biotechnology Co., LTD Business Overview
Table 98. Beijing Cellapy biotechnology Co., LTD Cardiac Disease Stem Cell Therapy Product
Table 99. Beijing Cellapy biotechnology Co., LTD Revenue in Cardiac Disease Stem Cell Therapy Business (US$ Million), 2021–2026
Table 100. Beijing Cellapy biotechnology Co., LTD Recent Development
Table 101. CardioCell Company Details
Table 102. CardioCell Business Overview
Table 103. CardioCell Cardiac Disease Stem Cell Therapy Product
Table 104. CardioCell Revenue in Cardiac Disease Stem Cell Therapy Business (US$ Million), 2021–2026
Table 105. CardioCell Recent Development
Table 106. Heartseed Company Details
Table 107. Heartseed Business Overview
Table 108. Heartseed Cardiac Disease Stem Cell Therapy Product
Table 109. Heartseed Revenue in Cardiac Disease Stem Cell Therapy Business (US$ Million), 2021–2026
Table 110. Heartseed Recent Development
Table 111. EmCell Company Details
Table 112. EmCell Business Overview
Table 113. EmCell Cardiac Disease Stem Cell Therapy Product
Table 114. EmCell Revenue in Cardiac Disease Stem Cell Therapy Business (US$ Million), 2021–2026
Table 115. EmCell Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
Table 119. Authors List of This Report
List of Figures
Figure 1. Cardiac Disease Stem Cell Therapy Picture
Figure 2. Global Cardiac Disease Stem Cell Therapy Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Cardiac Disease Stem Cell Therapy Market Share by Type: 2025 vs 2032
Figure 4. Autologous Features
Figure 5. Allogeneic Features
Figure 6. Global Cardiac Disease Stem Cell Therapy Market Size by Application (US$ Million), 2021–2032
Figure 7. Global Cardiac Disease Stem Cell Therapy Market Share by Application: 2025 vs 2032
Figure 8. Preclinical Case Studies
Figure 9. Clinical Phase 1,2 Case Studies
Figure 10. Cardiac Disease Stem Cell Therapy Report Years Considered
Figure 11. Global Cardiac Disease Stem Cell Therapy Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 12. Global Cardiac Disease Stem Cell Therapy Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Cardiac Disease Stem Cell Therapy Market Share by Region: 2025 vs 2032
Figure 14. Global Cardiac Disease Stem Cell Therapy Market Share by Players in 2025
Figure 15. Global Cardiac Disease Stem Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 16. The Top 10 and 5 Players Market Share by Cardiac Disease Stem Cell Therapy Revenue in 2025
Figure 17. North America Cardiac Disease Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 18. North America Cardiac Disease Stem Cell Therapy Market Share by Country (2021–2032)
Figure 19. United States Cardiac Disease Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 20. Canada Cardiac Disease Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 21. Europe Cardiac Disease Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. Europe Cardiac Disease Stem Cell Therapy Market Share by Country (2021–2032)
Figure 23. Germany Cardiac Disease Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. France Cardiac Disease Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. U.K. Cardiac Disease Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. Italy Cardiac Disease Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. Russia Cardiac Disease Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Ireland Cardiac Disease Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Asia-Pacific Cardiac Disease Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Asia-Pacific Cardiac Disease Stem Cell Therapy Market Share by Region (2021–2032)
Figure 31. China Cardiac Disease Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Japan Cardiac Disease Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. South Korea Cardiac Disease Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Southeast Asia Cardiac Disease Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. India Cardiac Disease Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Australia & New Zealand Cardiac Disease Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Latin America Cardiac Disease Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Latin America Cardiac Disease Stem Cell Therapy Market Share by Country (2021–2032)
Figure 39. Mexico Cardiac Disease Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Brazil Cardiac Disease Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Middle East & Africa Cardiac Disease Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Middle East & Africa Cardiac Disease Stem Cell Therapy Market Share by Country (2021–2032)
Figure 43. Israel Cardiac Disease Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Saudi Arabia Cardiac Disease Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. UAE Cardiac Disease Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Pharmicell Revenue Growth Rate in Cardiac Disease Stem Cell Therapy Business (2021–2026)
Figure 47. Gencell Revenue Growth Rate in Cardiac Disease Stem Cell Therapy Business (2021–2026)
Figure 48. BlueRock Therapeutics Revenue Growth Rate in Cardiac Disease Stem Cell Therapy Business (2021–2026)
Figure 49. Cellino Biotech Revenue Growth Rate in Cardiac Disease Stem Cell Therapy Business (2021–2026)
Figure 50. Mesoblast Revenue Growth Rate in Cardiac Disease Stem Cell Therapy Business (2021–2026)
Figure 51. BioCardia Revenue Growth Rate in Cardiac Disease Stem Cell Therapy Business (2021–2026)
Figure 52. Cedars-Sinai Revenue Growth Rate in Cardiac Disease Stem Cell Therapy Business (2021–2026)
Figure 53. Stem Cells Transplant Institute Revenue Growth Rate in Cardiac Disease Stem Cell Therapy Business (2021–2026)
Figure 54. CCTRN Revenue Growth Rate in Cardiac Disease Stem Cell Therapy Business (2021–2026)
Figure 55. Help Therapeutics Co., Ltd. Revenue Growth Rate in Cardiac Disease Stem Cell Therapy Business (2021–2026)
Figure 56. Beijing Cellapy biotechnology Co., LTD Revenue Growth Rate in Cardiac Disease Stem Cell Therapy Business (2021–2026)
Figure 57. CardioCell Revenue Growth Rate in Cardiac Disease Stem Cell Therapy Business (2021–2026)
Figure 58. Heartseed Revenue Growth Rate in Cardiac Disease Stem Cell Therapy Business (2021–2026)
Figure 59. EmCell Revenue Growth Rate in Cardiac Disease Stem Cell Therapy Business (2021–2026)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
